<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The first case of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of brain in a patient with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) was reported </plain></SENT>
<SENT sid="1" pm="."><plain>A 68-year-old man was admitted because of <z:hpo ids='HP_0001903'>anemia</z:hpo>, <z:hpo ids='HP_0001945'>fever</z:hpo>, and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and was diagnosed as having <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (<z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts) on the basis of the findings of bone marrow <z:hpo ids='HP_0002835'>aspiration</z:hpo> and chromosomal analysis </plain></SENT>
<SENT sid="2" pm="."><plain>The patient was followed up without chemotherapy, but a <z:mp ids='MP_0009277'>brain tumor</z:mp> appeared after 3 years </plain></SENT>
<SENT sid="3" pm="."><plain>Histologic and immunohistologic examinations revealed diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Mutations of the c-kit proto-oncogene (stem cell factor receptor) and the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressor gene were examined in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> lesion and malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (ML) by the polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP) method followed by direct sequencing </plain></SENT>
<SENT sid="5" pm="."><plain>The p53 mutation was not found in either <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or ML, but a nonsense mutation (Try-557 --&gt; stop) in exon 11 of the c-kit, which might lead to dysfunction of tyrosine kinase activity, was detected in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>This is the first report of c-kit mutation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Epstein-Barr virus (EBV) genome was demonstrated in the nucleus of brain ML cells by in situ hybridization with EBV-encoded <z:chebi fb="40" ids="33697">RNA</z:chebi>-1 probe </plain></SENT>
<SENT sid="8" pm="."><plain>Immunohistochemistry showed that the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells expressed <z:e sem="disease" ids="C0872054" disease_type="Disease or Syndrome" abbrv="">latent infection</z:e> gene products, including EBV nuclear antigen-2 and latent membrane protein-1 </plain></SENT>
<SENT sid="9" pm="."><plain>This pattern of latent gene expression was Lat III, which is usually found in malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> developing in immunocompromised hosts </plain></SENT>
<SENT sid="10" pm="."><plain>These findings suggest that a profound <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> resulted in an immunodeficient condition, after which EBV-positive B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of brain developed </plain></SENT>
</text></document>